Anxiety Disorders:  Future Directions for Research and Treatment

Next | Previous | Table of contents

References

American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). Washington, D.C.: Author.

American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd ed., revised). Washington, D.C.: Author.

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, D.C.: Author.

Angst, J., and Vollrath, M. (1991). The natural history of anxiety disorders. Acta Psychiatrica Scandinavica, 84, 446-452.

Antony, M.M., and Barlow, D.H. (1996). Emotion theory as a framework for explaining panic attacks and panic disorder. In R.M. Rapee (Ed.), Current controversies in the anxiety disorders. New York: Guilford Press.

Antony, M.M., and Barlow, D.H. (in press). Social and specific phobias . In A. Tasman, J. Kay, and J.A. Lieberman (Eds.), Psychiatry. Orlando, FL: W.B. Saunders Company.

Antony, M.M., Brown, T.A., and Barlow, D.H. (1992). Current perspectives on panic and panic disorder. Current Directions in Psychological Science, 1, 79-82.

Antony, M.M., Craske, M.G., and Barlow, D.H. (1995). Mastery of your specific phobia. Albany, NY: Graywind Publications.

Aronson, T.A., and Craig, T.J. (1986). Cocaine precipitation of panic disorder. American Journal of Psychiatry, 143, 643-645.

Aronson, T.A., and Logue, C.M. (1987). On the longitudinal course of panic disorder: Developmental history and predictors of phobic complications. Comprehensive Psychiatry, 28, 344-355.

Ballenger, J.C., Burrows, G.D., DuPont, R.L., Lesser, I.M., Noyes, R., Jr., Pecknold, J.C., Rifkin, A., and Swinson, R. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. Archives of General Psychiatry, 45, 413-422.

Barlow, D.H. (1988). Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford Press.

Barlow, D.H., O'Brien, G.T., and Last, C.G. (1984). Couples treatment of agoraphobia. Behaviour Therapy, 15, 41-58.

Barlow, D.H., Rapee, R.M., and Brown, T.A. (1992). Behavioral treatment of generalized anxiety disorder. Behavior Therapy, 23, 551-570.

Basoglu, M., Marks, I.M., Kilic, C., Brewin, C.R., and Swinson, R.P. (1994). Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164, 652-659.

Beauclair, L., Fontaine, R., Annable, L., Holobow, N., and Chouinard, G. (1994). Clonazepam in the treatment of panic disorder: A double-blind, placebo-controlled trail investigating the correlation between clonazepam concentrations in plasma and clinical response. Journal of Clinical Psychopharmacology, 14, 111-118.

Bland, R.C., Orn, H., and Newman, S.C. (1988). Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica, 77(Suppl. 338), 24-32.

Borkovec, T.D., and Costello, E. (1993). Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61, 611-619.

Borkovec, T.D., Mathews, A.M., Chambers, A., Ebrahimi, S., Lytle, R., and Nelson, R. (1987). The effects of relaxation training with cognitive or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. Journal of Consulting and Clinical Psychology, 55, 883-888.

Bourdon, K.H., Boyd, J.H., Rae, D.S., Burns, B.J., Thompson, J.W., and Locke, B.Z. (1988). Gender differences in phobias: Results of the ECA community study. Journal of Anxiety Disorders, 2, 227-241.

Bourque, P. and Ladouceur, R. (1980). An investigation of various performance-based treatments with agoraphobics. Behaviour Research and Therapy, 18, 161-170.

Brown, T.A., Antony, M.M., and Barlow, D.H. (1995). Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychology, 63, 408-418.

Bruch, M.A. (1989). Familial and developmental antecedents of social phobia: Issues and findings. Clinical Psychology Review, 9, 37-47.

Bruch, M.A., and Heimberg, R.G. (1994). Differences in perceptions of parental and personal characteristics between generalized and nongeneralized social phobics. Journal of Anxiety Disorders, 8, 155-168.

Butler, G., Cullington, A., Munby, M., Amies, P., and Gelder, M. (1984). Exposure and anxiety management in the treatment of social phobia. Journal of Consulting and Clinical Psychology, 52, 642-650.

Carter, C.S., Fawcett, J., Hertzman, M., Papp, L.A., Jones, W., Patterson, W.M., Swinson, R. P., Weise, C.C., Maddock, R.J., Denahan, A.Q., and Liebowitz, M. (1995). Adinazolam-SR in panic disorder with agoraphobia: Relationship of daily dose to efficacy. Journal of Clinical Psychopharmacology, 56, 202-210.

Cerny, J.A., Barlow, D.H., Craske, M.G., and Himadi, W.G. (1987). Couples treatment of agoraphobia: A two-year follow-up. Behaviour Therapy, 18, 401-415.

Chen, Y.-W., and Dilsaver, S.C. (1995). Comorbidity of panic disorder in bipolar illness: Evidence from the Epidemiological Catchment Area Survey. American Journal of Psychiatry, 152, 280-282.

Chouinard, G., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., White, K., Hackett, E., Gaffney, M., and Bick, P.A. (1990). Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmocology Bulletin, 26, 279-284.

Clark, D.M., Salkovskis, P.M., Hackmann, A., Middleton, H., Anastasiades, P., and Gelder, M. (1994). A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry, 164, 759-769.

Clomipramine Collaborative Study Group (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 730-738.

Clum, G.A., Clum, G.A., and Surls, R. (1993). A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology, 61, 317-326.

Cohen, S.D., Monteiro, W., and Marks, I.M. (1984). Two-year follow- up of agoraphobics after exposure and imipramine. British Journal of Psychiatry, 144, 276-281.

Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A., Douge, R., and Cialdella, P. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmocology, 5, 17- 30.

Cox, B.J., Norton, G.R., Swinson, R.P., and Endler, N.S. (1990). Substance abuse and panic-related anxiety: A critical review. Behaviour Research and Therapy, 28, 385-393.

Cox, B.J., Swinson, R.P., Morrison, B., and Lee, P.S. (1993). Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: A meta-analysis. Journal of Behavioral Therapy and Experimental Psychiatry, 24, 149-153.

Cross-National Collaborative Panic Study, Second Phase Investigators (1992). Drug treatment of panic disorder. British Journal of Psychiatry, 160, 191-202.

Davidson, J., Kudler, H., Smith, R., Mahorney, S. L., Lipper, S., Hammett, E., Saunders, W. B., and Cavenar, J.O., Jr. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259-266.

Davidson, J.R.T., Potts, N., Richichi, E., Krishnan, R., Ford, S.M., Smith, R., and Wilson, W.H. (1993). Treatment of social phobia with clonazepam and placebo. Journal of Clinical Psychopharmacology, 13, 423-428.

de Beurs, E., van Balkom, A.J., Lange, A., Koele, P., and van Dyke, R. (1995). Treatment of panic disorder with agoraphobia: Comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. American Journal of Psychiatry, 152, 683-691.

Durham, R.C., Murphy, T., Allan, T., Richard, K., Treliving, L.R., and Fenton, G.W. (1994). Cognitive therapy, analytic psychotherapy and anxiety management training for generalized anxiety disorder. British Journal of Psychiatry, 165, 315-323.

Fahlen, T., Nilsson, H.L., Borg, K., Humble, M., and Pauli, U. (1995). Social phobia: The clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor Brofaromine. Acta Psychiatrica Scandinavica, 92, 351-358.

Fals-Stewart, W., Marks, A.P., and Schafer, J. (1993). A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. Journal of Nervous and Mental Disease, 181, 189-193.

Faravelli, C., and Pallanti, S. (1989). Recent life events and panic disorder. American Journal of Psychiatry, 146, 622- 626.

Fava, G.A., Zielezny, M., Luria, E., and Canestrari, R. (1988). Obsessive-compulsive symptoms in agoraphobia: Changes with treatment. Psychiatry Research, 23, 57-63.

Feske, U., and Chambless, D.L. (1995). Cognitive-behavioral versus exposure only treatment for social phobia: A meta-analysis. Behavior Therapy, 26, 695-720.

Foa, E.B., and Goldstein, A. (1978). Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy, 9, 821-829.

Foa, E.B., Herst-Ikeda, D., and Perry, K.J. (1995). Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. Journal of Consulting and Clinical Psychology, 63, 948-955.

Fyer, A.J., Mannuzza, S., Chapman, T.F., Martin, L.Y., and Klein, D.F. (1995). Specificity in familial aggregation of phobic disorders. Archives of General Psychiatry, 52, 564-573.

Gelernter, C.S., Uhde, T.W., Cimbolic, P., Arnkoff, D.B., Vittone, B.J., and Tancer, M.E. (1991). Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study. Archives of General Psychiatry, 48, 938-945.

Gerlsma, C., Emmelkamp, P.M.G., and Arrindell, W.A. (1990). Anxiety, depression, and perception of early parenting: A meta-analysis. Clinical Psychology Review, 10, 251-277.

Gould, R.A., Clum, G.A., and Shapiro, D. (1993). The use of bibliotherapy in the treatment of panic: A preliminary investigation. Behavior Therapy, 24, 241-252.

Health Canada. (1994). Evaluation of Programs for the Treatment of Schizophrenia: A Health Economic Perspective. Ottawa: Minister of Supply and Services Canada.

Health Canada. (1996). Quality of Life Measurement Among Persons with Chronic Mental Illness: A Critique of Measures and Methods. Ottawa: Minister of Supply and Services Canada.

Hecker, J.E., Fink, C.M., and Fritzler, B.K. (1993). Acceptability of panic disorder treatments: A survey of family practice physicians. Journal of Anxiety Disorders, 7, 373-384.

Heimberg, R.G., Dodge, C.S., Hope, D.A., Kennedy, C.R., and Zollo, L.J. (1990). Cognitive- behavioral group treatment for social phobia: Comparison with a credible placebo control. Cognitive Therapy and Research, 14, 1-23.

Heimberg, R.G., Juster, H.R., Brown, E.J., Holle, C., Schneier, F.R., and Gitow, A. (1994, November). Cognitive-behavioral versus pharmacological treatment of social phobia: Posttreatment and follow-up effects. Paper presented at the Annual Meeting of the Association for Advancement of Behavior Therapy, San Diego, CA.

Hoehn-Saric, R., McLeod, D. R., and Zimmerli, W.D. (1988). Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic symptoms. Journal of Clinical Psychiatry, 49, 293-301.

Jerremalm, A., Jansson, L, and Öst, L.-G. (1986). Individual response patterns and the effects of different behavioral methods in the treatment of dental phobia. Behaviour Research and Therapy, 24, 587-596.

Johnston, D.G., Troyer, I.E., and Whitsett, S.F. (1988). Clomipramine treatment of agoraphobic women: An eight-week controlled trial. Archives of General Psychiatry, 45, 453- 459.

Katzelnick, D.J., Kobak, K.A., Greist, J.H., Jefferson, J.W., Mantle, J.M., and Serlin, R.C. (1995). Sertraline for social phobia: A double-blind, placebo-controlled crossover study. American Journal of Psychiatry, 152, 1368-1371.

Keane, T.M., Fairbank, J.A., Caddell, J.M., and Zimering, R.T. (1989). Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behavior Therapy, 20, 245- 260.

Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., and Eaves, L.J. (1992). The genetic epidemiology of phobias in women: The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Archives of General Psychiatry, 49, 273-281.

Kessler R.C., McGonagle K.A., Zhao S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen H.-U., and Kendler, K. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8- 19.

Keyl, P.M., and Eaton, W.W. (1990). Risk factors for the onset of panic disorder and panic attacks in a prospective, population-based study. American Journal of Epidemiology, 131, 301-311.

Klein, E., Colin, V., Stolk, J., and Lenox, R.H. (1994). Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: Vulnerability and effect of carbamazepine. American Journal of Psychiatry, 151, 1760- 1766.

Kosten, T.R., Frank, J.B., Dan, E., McDougle, C.J., and Giller, E.L., Jr. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. The Journal of Nervous and Mental Disease, 179, 366-370.

Kushner, M.G., Sher, K.J., and Beitman, B.D. (1990). The relation between alcohol problems and the anxiety disorders. American Journal of Psychiatry, 147, 685-695.

Lelliott, P.T., Marks, I.M., Monteiro, W.O., Tsakiris, F., and Noshirvani, H. (1987). Agoraphobics 5 years after imipramine and exposure: Outcome and predictors. Journal of Nervous and Mental Disease, 175, 599-605.

Leon, A.C., Portera, L., and Weissman, M.M. (1995). The social costs of anxiety disorders. British Journal of Psychiatry, 166(suppl. 27). 19-22.

Liebowitz, M.R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., and Fyer, A.J. (1992). Phenelzine vs atenolol in social phobia: A placebo-controlled comparison. Archives of General Psychiatry, 49, 290-300.

MacDonald, A.M., and Murray, R.M. (1994). The genetics of anxiety disorders. In B.B. Wolman and G. Stricker (Eds.), Anxiety and related disorders: A handbook. New York: John Wiley and Sons.

Marks, I.M., Gray, S., Cohen, D., Hill, R., Mawson, D., Ramm, E., and Stern, R.S. (1983). Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Archives of General Psychiatry, 40, 153-162.

Marks, I.M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., and Kasvikis, Y. (1988). Clomipramine, self-exposure and therapist-aided exposure for obsessive- compulsive rituals. British Journal of Psychiatry, 152, 522-534.

Marks, I.M., Swinson, R.P., Basoglu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P.T., Kirby, M., McNamee, G., Sengun, S., and Wickwire, K. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776-787.

Mavissakalian, M.R., and Perel, J.M. (1995). Imipramine treatment of panic disorder with agoraphobia: Dose ranging and plasma level-response relationships. American Journal of Psychiatry, 152, 673-682.

McCarley, T., Steinberg, A., Spears, M., and Essock-Vitale, S. (1987). Integrating biological and psychosocial therapies: A survey of psychiatric training, practice, and attitudes. Journal of Psychiatric Education, 11, 43-53.

Newman, M.G., Hofmann, S.G., Trabert, W., Roth, W.T., and Taylor, C.B. (1994). Does behavioral treatment of social phobia lead to cognitive changes? Behavior Therapy, 25, 503-517.

Noyes, R., Jr., DuPont, R.L., Pecknold, J.C., Rifkin, A., Rubin, R.T., Swinson, R.P., Ballenger, J.C., and Burrows, G.D. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: Patient acceptance, side effects, and safety. Archives of General Psychiatry, 45, 423-428.

Noyes, R., Jr., Garvey, M.J., Cook, B., and Suelzer, M. (1991). Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517-523.

Ontario Ministry of Health. (1994). Ontario Health Survey 1990: Mental Health Supplement. Toronto: Ontario Ministry of Health.

Öst, L.-G. (1989). One-session treatment for specific phobias. Behaviour Research and Therapy, 27, 1-7.

Öst, L.-G., Fellenius, J., and Sterner, U. (1991). Applied tension, exposure in vivo, and tension-only in the treatment of blood phobia. Behaviour Research and Therapy, 29, 561- 574.

Öst, L.-G., Johansson, J., and Jerremalm, A. (1982). Individual response patterns and the effects of different behavioral methods in the treatment of claustrophobia. Behaviour Research and Therapy, 20, 445-460.

Öst, L.-G., Lindahl, I.L., Sterner, U., and Jerremalm, A. (1984). Exposure in vivo vs. applied relaxation in the treatment of blood phobia. Behaviour Research and Therapy, 22, 205- 216.

Öst, L.-G., Salkovskis, P.M., and Hellström, K. (1991). One-session therapist-directed exposure vs. self-exposure in the treatment of spider phobia. Behavior Therapy, 22, 407-422.

Otto, M.W., Pollack, M.H., Sachs, G.S., Reiter, S.R., Meltzer-Brody, S., and Rosenbaum, J.F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.

Pauls, D.L., Alsobrook, J.P., Goodman, W., Rasmussen, S., and Leckman, J.F. (1995). A family study of obsessive-compulsive disorder. American Journal of Psychiatry, 152, 76-84.

Pecknold, J.C., Swinson, R.P., Kuch, K., and Lewis, C.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: Discontinuation effects. Archives of General Psychiatry, 45, 429-436.

Perse, T.L., Greist, J.H., Jefferson, J.W., Rosenfeld, R., and Dar, R. (1987). Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1543-1548.

Pollard, C.A., Henderson, J.G., Frank, M., and Margolis, R.B. (1989). Help-seeking patterns of anxiety disordered individuals in the general population. Journal of Anxiety Disorders, 3, 131-138.

Pollard, C.A., Pollard, H.J., and Corn, K.J. (1989). Panic onset and major events in the lives of agoraphobics: A test of contiguity. Journal of Abnormal Psychology, 98, 318-321.

Power, K.G., Simpson, R.J., Swanson, V., and Wallace, L.A. (1990). A controlled comparison of cognitive-behaviour therapy, diazepam, and placebo, alone and in combination, for the treatment of generalized anxiety disorder. Journal of Anxiety Disorders, 4, 267-292.

Rickels, K., Downing, R., Schweizer, E., and Hassman, H. (1993). Antidepressants for the treatment of generalized anxiety disorder. Archives of General Psychiatry, 50, 884-895.

Rickels, K., Schweizer, E., Weiss, S., and Zavodnick, S. (1993). Maintenance drug treatment for panic disorder: Short- and long-term outcome after drug taper. Archives of General Psychiatry, 50, 61-68.

Rickels, K., Weisman, K., Norstad, N., Singer, M., Stoltz, D., and Brown, A. (1982). Buspirone and diazepam in anxiety: A controlled study. Journal of Clinical Psychiatry, 43, 81- 86.

Robins, L.N., Helzer, J.E., Croughan, J.L., and Ratcliff, K.S. (1981). National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics and validity. Archives of General Psychiatry, 38, 381-389.

Robins, L.N., Helzer, J.E., Weissman, M.M., Orvaschel, H., Gruenberg, E., Burke, J.D., and Regier, D.A. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949-958.

Robins, L.N., Wing, J., Wittchen, H.U., and Helzer, J.E. (1988). The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45, 1069-1077.

Romeder, Jean-Marie. (1993). Of surveys and definitions of self-help and mutual aid. Self-help/mutual aid for seniors: Research challenges, report of the discussion session at the Canadian Association of Gerontology in Montreal on October 30, 1993. Ottawa: Self-Help Canada.

Roy-Byrne, P.P., and Uhde, T.W. (1988). Exogenous factors in panic disorder: Clinical and research implications. Journal of Clinical Psychiatry, 49, 56-61.

Roy-Byrne, P.P., Geraci, M., and Uhde, T.W. (1986). Life events and the onset of panic disorder. American Journal of Psychiatry, 143, 1424-1427.

Sacchetti, E., Zerbini, O., Banfi, F., and Tansella, M. (1994). Overlap of buspirone with lorazepam, diazepam and bromazepam in patients with generalized anxiety disorder: Findings from a controlled, multicentre double-blind study. Human Psychopharmacology, 9, 409-422.

Salvador-Carulla, Segui, J., Fernandez-Cano, P., and Canet, J. (1995). Costs and offset effect in panic disorders. British Journal of Psychiatry, 166(suppl. 27), 23-28

Sanderson, W.C., Beck, A.T., and Betz, F. (1991, November). Prevalence of personality disorders among patients with anxiety disorders. Paper presented at the annual meeting of the Association for Advancement of Behavior Therapy, New York, NY.

Sanderson, W.C., Di Nardo, P.A., Rapee, R.M., and Barlow, D.H. (1990). Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology, 99, 308-312.

Schweizer, E., Pohl, R., Balon, R., Fox, I., Rickels, K., and Yeragani, V.K. (1990). Lorazepam vs. alprazolam in the treatment of panic disorder. Pharmacopsychiatry, 23, 90-93.

Siegel, L., Jones, W.C., and Wilson, J.O. (1990). Economic and life consequences experienced by a group of individuals with panic disorder. Journal of Anxiety Disorders, 4, 201-211.

Silove, Parker, Hadzi-Pavlovic, Manicavasagar, and Blaszczynski, A. (1991). Parental representations of patients with panic disorder and generalized anxiety disorder. British Journal of Psychiatry, 159, 835-841.

Simon, G., Ormel, J., VonKorff, M., and Barlow, W. (1995). Health care costs associated with depressive and anxiety disorders in primary care. American Journal of Psychiatry, 152, 352- 357.

Stein, D.J., Hollander, E., and Skodol, A.E. (1993). Anxiety disorders and personality disorders: A review. Journal of Personality Disorders, 7, 87-104.

Swinson, R.P., Cox, B.J., and Woszczyna, C.B. (1992). Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. Canadian Medical Association Journal, 147, 878-883.

Swinson, R.P., Cox, B.J., Kerr, S.A., Kuch, K., and Fergus, K.D. (1992). A survey of anxiety disorders clinics in Canadian hospitals. Canadian Journal of Psychiatry, 37, 188-191.

Swinson, R.P., Fergus, K.D., Cox, B.J., and Wickwire, K. (1995). Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia. Behaviour Research and Therapy, 33, 465-469.

Telch, M.J., Agras, W.S., Taylor, C.B., Roth, W.T., and Gallen, C.C. (1985). Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy, 23, 325-335.

Thorén, P., Åsberg, M., Cronholm, B., Jörnestedt, L., and Träskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder: A controlled clinical trial. Archives of General Psychiatry, 37, 1281-1285.

Tollefson, G.D., Rampey, A.H., Potvin, J.H., Jenike, M.A., Rush, A.J., Dominguez, R.A., Koran, L.M., Shear, M.K., Goodman, W., and Genduso, L.A. (1994). A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51, 559-567.

van Ameringen, M., Mancini, C., Styan, G., and Donison, D. (1991). Relationship of social phobia with other psychiatric illness. Journal of Affective Disorders, 21, 93-99.

van Balkom, A.J., van Oppen, P., Vermeulen, A.W., and van Dyck, R. (1994). A meta-analysis on the treatment of obsessive-compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review, 14, 359-381.

Welkowitz, L.A., Papp, L.A., Cloitre, M., Liebowitz, M.R., Martin, L.Y., and Gorman, J.M. (1991). Cognitive-behavioral therapy for panic disorder delivered by psychopharmacologically-oriented clinicians. Journal of Nervous and Mental Disease, 179, 473-477.

Next | Previous | Table of contents